The invention provides a novel & cost-efficient process of concentrating rotavirus to obtain gel-adsorbed rotaviral liquid compositions,wherein the viral titer post-adsorption is atleast 10 fold greater than the pre-adsorption viral titer with partial removal of nucleic acid contaminants.Also present invention provides stable vaccine formulations of such live and inactivated rotavirus.